{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:34:54Z","timestamp":1769042094158,"version":"3.49.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T00:00:00Z","timestamp":1704412800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T00:00:00Z","timestamp":1704412800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/K0019494\/1"],"award-info":[{"award-number":["MR\/K0019494\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/R023026\/1"],"award-info":[{"award-number":["MR\/R023026\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Wellcome Trust Institutional Strategic Support Fund"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Synaptophysin is expressed on fibrogenic hepatic myofibroblasts. C1\u20133 is a single chain human antibody (scAb) that binds specifically to synaptophysin on hepatic myofibroblasts, providing a targeting vector for novel in vivo imaging agents of chronic liver disease. C1\u20133 and a negative control scAb, CSBD9, were radiolabelled with zirconium-89 via desferrioxamine chelation to enable non-invasive molecular imaging with positron emission tomography (PET). DFO-scAb conjugates were characterised by gel electrophoresis (SDS-PAGE) and MALDI-TOF spectrometry, and <jats:sup>89<\/jats:sup>Zr-labelled with high radiolabelling efficiency (99%). [<jats:sup>89<\/jats:sup>Zr]Zr-DFO-C1\u20133 exhibited high in vitro stability (&gt;\u200999%) in mouse and human sera over 3 days at 25 and 37 \u00b0C. Activated hepatic myofibroblasts incubated with [<jats:sup>89<\/jats:sup>Zr]Zr-DFO-C1\u20133 displayed significantly higher internalised activity (59.46%, P\u2009=\u20090.001) compared to the [<jats:sup>89<\/jats:sup>Zr]Zr-DFO-CSBD9 control, indicating synaptophysin-mediated uptake and high binding specificity of [<jats:sup>89<\/jats:sup>Zr]Zr-DFO-C1\u20133. Mice with CCl<jats:sub>4<\/jats:sub>-induced acute liver damage exhibited significantly higher liver uptake of [<jats:sup>89<\/jats:sup>Zr]Zr-DFO-C1\u20133, compared to controls, confirmed by both Cerenkov imaging and ex vivo gamma counting (4.41\u2009\u00b1\u20090.19%ID\/g, P\u2009&lt;\u20090.0001). CCl<jats:sub>4<\/jats:sub>-induced liver damage and the number of hepatic myofibroblasts was confirmed by \u03b1SMA staining of liver sections. These findings indicate that [<jats:sup>89<\/jats:sup>Zr]Zr-DFO-C1\u20133 has promising utility as a PET imaging agent for non-invasive detection of hepatic myofibroblasts following acute liver injury.<\/jats:p>","DOI":"10.1038\/s41598-023-50779-w","type":"journal-article","created":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T15:02:37Z","timestamp":1704466957000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Synthesis and preclinical evaluation of a 89Zr-labelled human single chain antibody for non-invasive detection of hepatic myofibroblasts in acute liver injury"],"prefix":"10.1038","volume":"14","author":[{"given":"Toni A.","family":"Pringle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik","family":"Ramon-Gil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jack","family":"Leslie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fiona","family":"Oakley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew C.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James C.","family":"Knight","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saimir","family":"Luli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,1,5]]},"reference":[{"issue":"1","key":"50779_CR1","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jhep.2018.09.014","volume":"70","author":"SK Asrani","year":"2019","unstructured":"Asrani, S. K., Devarbhavi, H., Eaton, J. & Kamath, P. S. Burden of liver diseases in the world. J. Hepatol. 70(1), 151\u2013171 (2019).","journal-title":"J. Hepatol."},{"issue":"5","key":"50779_CR2","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1002\/cld.1061","volume":"17","author":"S Cheemerla","year":"2021","unstructured":"Cheemerla, S. & Balakrishnan, M. Global epidemiology of chronic liver disease. Clin. Liver Dis. 17(5), 365\u2013370 (2021).","journal-title":"Clin. Liver Dis."},{"issue":"1","key":"50779_CR3","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1002\/hep.29466","volume":"67","author":"C Estes","year":"2018","unstructured":"Estes, C., Razavi, H., Loomba, R., Younossi, Z. & Sanyal, A. J. Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease. Hepatology 67(1), 123\u2013133 (2018).","journal-title":"Hepatology"},{"issue":"4","key":"50779_CR4","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.jhep.2018.05.036","volume":"69","author":"C Estes","year":"2018","unstructured":"Estes, C. et al. Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016\u20132030. J. Hepatol. 69(4), 896\u2013904 (2018).","journal-title":"J. Hepatol."},{"issue":"6","key":"50779_CR5","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","volume":"78","author":"ME Rinella","year":"2023","unstructured":"Rinella, M. E. et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. J. Hepatol. 78(6), 1966 (2023).","journal-title":"J. Hepatol."},{"issue":"3","key":"50779_CR6","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41575-020-00372-7","volume":"18","author":"T Kisseleva","year":"2021","unstructured":"Kisseleva, T. & Brenner, D. Molecular and cellular mechanisms of liver fibrosis and its regression. Nat. Rev. Gastroenterol. Hepatol. 18(3), 151\u2013166 (2021).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"3","key":"50779_CR7","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1002\/hep.27332","volume":"61","author":"E Seki","year":"2015","unstructured":"Seki, E. & Schwabe, R. F. Hepatic inflammation and fibrosis: Functional links and key pathways. Hepatology 61(3), 1066\u20131079 (2015).","journal-title":"Hepatology"},{"issue":"1","key":"50779_CR8","doi-asserted-by":"publisher","first-page":"G110","DOI":"10.1152\/ajpgi.00412.2010","volume":"301","author":"AL Olsen","year":"2011","unstructured":"Olsen, A. L. et al. Hepatic stellate cells require a stiff environment for myofibroblastic differentiation. Am. J. Physiol. Gastrointest. Liver Physiol. 301(1), G110\u2013G118 (2011).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"24","key":"50779_CR9","doi-asserted-by":"publisher","first-page":"9448","DOI":"10.1073\/pnas.1201840109","volume":"109","author":"T Kisseleva","year":"2012","unstructured":"Kisseleva, T. et al. Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis. Proc. Natl. Acad. Sci. U.S.A. 109(24), 9448\u20139453 (2012).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"7","key":"50779_CR10","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","volume":"14","author":"T Tsuchida","year":"2017","unstructured":"Tsuchida, T. & Friedman, S. L. Mechanisms of hepatic stellate cell activation. Nat. Rev. Gastroenterol. Hepatol. 14(7), 397\u2013411 (2017).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"12","key":"50779_CR11","first-page":"759","volume":"100","author":"A Smith","year":"2019","unstructured":"Smith, A., Baumgartner, K. & Bositis, C. Cirrhosis: Diagnosis and management. Am. Fam. Phys. 100(12), 759\u2013770 (2019).","journal-title":"Am. Fam. Phys."},{"issue":"7","key":"50779_CR12","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1136\/gut.2010.214650","volume":"59","author":"L Castera","year":"2010","unstructured":"Castera, L. & Pinzani, M. Biopsy and non-invasive methods for the diagnosis of liver fibrosis: Does it take two to tango? Gut 59(7), 861\u2013866 (2010).","journal-title":"Gut"},{"issue":"2","key":"50779_CR13","doi-asserted-by":"publisher","first-page":"475","DOI":"10.3748\/wjg.v20.i2.475","volume":"20","author":"Y Sumida","year":"2014","unstructured":"Sumida, Y., Nakajima, A. & Itoh, Y. Limitations of liver biopsy and non-invasive diagnostic tests for the diagnosis of nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis. World J. Gastroenterol. 20(2), 475\u2013485 (2014).","journal-title":"World J. Gastroenterol."},{"issue":"7","key":"50779_CR14","doi-asserted-by":"publisher","first-page":"3366","DOI":"10.1007\/s10620-021-07089-w","volume":"67","author":"HB Thomaides-Brears","year":"2022","unstructured":"Thomaides-Brears, H. B. et al. Incidence of complications from percutaneous biopsy in chronic liver disease: A systematic review and meta-analysis. Dig. Dis. Sci. 67(7), 3366\u20133394 (2022).","journal-title":"Dig. Dis. Sci."},{"issue":"7","key":"50779_CR15","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1053\/j.gastro.2005.03.084","volume":"128","author":"V Ratziu","year":"2005","unstructured":"Ratziu, V. et al. Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology 128(7), 1898\u20131906 (2005).","journal-title":"Gastroenterology"},{"issue":"2","key":"50779_CR16","doi-asserted-by":"publisher","first-page":"124","DOI":"10.4103\/1319-3767.61244","volume":"16","author":"FM Sanai","year":"2010","unstructured":"Sanai, F. M. & Keeffe, E. B. Liver biopsy for histological assessment: The case against. Saudi J. Gastroenterol. 16(2), 124\u2013132 (2010).","journal-title":"Saudi J. Gastroenterol."},{"issue":"1","key":"50779_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jhep.2008.10.014","volume":"50","author":"P Bedossa","year":"2009","unstructured":"Bedossa, P. & Carrat, F. Liver biopsy: The best, not the gold standard. J. Hepatol. 50(1), 1\u20133 (2009).","journal-title":"J. Hepatol."},{"issue":"6","key":"50779_CR18","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1053\/j.gastro.2004.08.052","volume":"127","author":"WM Rosenberg","year":"2004","unstructured":"Rosenberg, W. M. et al. Serum markers detect the presence of liver fibrosis: A cohort study. Gastroenterology 127(6), 1704\u20131713 (2004).","journal-title":"Gastroenterology"},{"key":"50779_CR19","first-page":"817","volume":"15","author":"MR McGill","year":"2016","unstructured":"McGill, M. R. The past and present of serum aminotransferases and the future of liver injury biomarkers. Excli. J. 15, 817\u2013828 (2016).","journal-title":"Excli. J."},{"issue":"5","key":"50779_CR20","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1097\/CM9.0000000000002027","volume":"135","author":"G Li","year":"2022","unstructured":"Li, G. et al. Non-invasive tests of non-alcoholic fatty liver disease. Chin. Med. J. 135(5), 532\u2013546 (2022).","journal-title":"Chin. Med. J."},{"issue":"7","key":"50779_CR21","doi-asserted-by":"publisher","first-page":"3238","DOI":"10.1007\/s00261-021-03019-6","volume":"46","author":"M Aksakal","year":"2021","unstructured":"Aksakal, M. et al. Diagnostic performance of 2D shear wave elastography in predicting liver fibrosis in patients with chronic hepatitis B and C: A histopathological correlation study. Abdom. Radiol. 46(7), 3238\u20133244 (2021).","journal-title":"Abdom. Radiol."},{"issue":"10","key":"50779_CR22","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1016\/j.cgh.2007.06.012","volume":"5","author":"M Yin","year":"2007","unstructured":"Yin, M. et al. Assessment of hepatic fibrosis with magnetic resonance elastography. Clin. Gastroenterol. Hepatol. 5(10), 1207\u20131213 (2007).","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"3","key":"50779_CR23","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1002\/jmri.23731","volume":"37","author":"SK Venkatesh","year":"2013","unstructured":"Venkatesh, S. K., Yin, M. & Ehman, R. L. Magnetic resonance elastography of liver: Technique, analysis, and clinical applications. J. Magn. Reson. Imaging 37(3), 544\u2013555 (2013).","journal-title":"J. Magn. Reson. Imaging"},{"issue":"12","key":"50779_CR24","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.dld.2009.04.002","volume":"41","author":"C Stasi","year":"2009","unstructured":"Stasi, C. et al. Transient elastography for the assessment of liver fibrosis in patients with chronic viral hepatitis: The missing tool? Dig. Liver Dis. 41(12), 863\u2013866 (2009).","journal-title":"Dig. Liver Dis."},{"issue":"2","key":"50779_CR25","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1148\/radiol.2020192437","volume":"296","author":"RG Barr","year":"2020","unstructured":"Barr, R. G., Wilson, S. R., Rubens, D., Garcia-Tsao, G. & Ferraioli, G. Update to the Society of Radiologists in ultrasound liver elastography consensus statement. Radiology 296(2), 263\u2013274 (2020).","journal-title":"Radiology"},{"issue":"1","key":"50779_CR26","doi-asserted-by":"publisher","first-page":"19786","DOI":"10.1038\/s41598-021-99243-7","volume":"11","author":"M Obrzut","year":"2021","unstructured":"Obrzut, M. et al. Postprandial hepatic stiffness changes on magnetic resonance elastography in healthy volunteers. Sci. Rep. 11(1), 19786\u201319792 (2021).","journal-title":"Sci. Rep."},{"issue":"3","key":"50779_CR27","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.jhep.2012.04.035","volume":"57","author":"M Polasek","year":"2012","unstructured":"Polasek, M. et al. Molecular MR imaging of liver fibrosis: A feasibility study using rat and mouse models. J. Hepatol. 57(3), 549\u2013555 (2012).","journal-title":"J. Hepatol."},{"issue":"5","key":"50779_CR28","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/j.jhep.2013.06.026","volume":"59","author":"BC Fuchs","year":"2013","unstructured":"Fuchs, B. C. et al. Molecular MRI of collagen to diagnose and stage liver fibrosis. J. Hepatol. 59(5), 992\u2013998 (2013).","journal-title":"J. Hepatol."},{"issue":"43","key":"50779_CR29","doi-asserted-by":"publisher","first-page":"8171","DOI":"10.1002\/anie.200700700","volume":"46","author":"P Caravan","year":"2007","unstructured":"Caravan, P. et al. Collagen-targeted MRI contrast agent for molecular imaging of fibrosis. Angew. Chem. Int. Ed. Engl. 46(43), 8171\u20138173 (2007).","journal-title":"Angew. Chem. Int. Ed. Engl."},{"issue":"1","key":"50779_CR30","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jhep.2016.03.021","volume":"65","author":"S Luli","year":"2016","unstructured":"Luli, S. et al. A new fluorescence-based optical imaging method to non-invasively monitor hepatic myofibroblasts in vivo. J. Hepatol. 65(1), 75\u201383 (2016).","journal-title":"J. Hepatol."},{"issue":"6","key":"50779_CR31","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1016\/S0002-9440(10)65501-0","volume":"155","author":"D Cassiman","year":"1999","unstructured":"Cassiman, D. et al. Synaptophysin: A novel marker for human and rat hepatic stellate cells. Am. J. Pathol. 155(6), 1831\u20131839 (1999).","journal-title":"Am. J. Pathol."},{"issue":"6","key":"50779_CR32","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1016\/j.jhep.2005.01.028","volume":"42","author":"LJ Elrick","year":"2005","unstructured":"Elrick, L. J. et al. Generation of a monoclonal human single chain antibody fragment to hepatic stellate cells\u2014A potential mechanism for targeting liver anti-fibrotic therapeutics. J. Hepatol. 42(6), 888\u2013896 (2005).","journal-title":"J. Hepatol."},{"issue":"1","key":"50779_CR33","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1038\/s41598-021-81097-8","volume":"11","author":"J Leslie","year":"2021","unstructured":"Leslie, J., Robinson, S. M., Oakley, F. & Luli, S. Non-invasive synchronous monitoring of neutrophil migration using whole body near-infrared fluorescence-based imaging. Sci. Rep. 11(1), 1415 (2021).","journal-title":"Sci. Rep."},{"issue":"1","key":"50779_CR34","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.jhep.2008.01.032","volume":"49","author":"A Douglass","year":"2008","unstructured":"Douglass, A. et al. Antibody-targeted myofibroblast apoptosis reduces fibrosis during sustained liver injury. J. Hepatol. 49(1), 88\u201398 (2008).","journal-title":"J. Hepatol."},{"issue":"3","key":"50779_CR35","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/j.bbrc.2004.02.137","volume":"316","author":"V Leel","year":"2004","unstructured":"Leel, V. et al. Identification of a truncated ratp28-related protein expressed in kidney. Biochem. Biophys. Res. Commun. 316(3), 872\u2013877 (2004).","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"50779_CR36","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/nprot.2015.017","volume":"10","author":"I Mederacke","year":"2015","unstructured":"Mederacke, I., Dapito, D. H., Aff\u00f2, S., Uchinami, H. & Schwabe, R. F. High-yield and high-purity isolation of hepatic stellate cells from normal and fibrotic mouse livers. Nat. Protoc. 10(2), 305\u2013315 (2015).","journal-title":"Nat. Protoc."},{"issue":"21","key":"50779_CR37","doi-asserted-by":"publisher","first-page":"3422","DOI":"10.21769\/BioProtoc.3422","volume":"9","author":"RV Modak","year":"2019","unstructured":"Modak, R. V. & Zaiss, D. M. Isolation and culture of murine hepatic stellate cells. Bio Protoc. 9(21), 3422\u20133430 (2019).","journal-title":"Bio Protoc."},{"issue":"3","key":"50779_CR38","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1053\/gast.2001.27188","volume":"121","author":"MC Wright","year":"2001","unstructured":"Wright, M. C. et al. Gliotoxin stimulates the apoptosis of human and rat hepatic stellate cells and enhances the resolution of liver fibrosis in rats. Gastroenterology 121(3), 685\u2013698 (2001).","journal-title":"Gastroenterology"},{"issue":"1","key":"50779_CR39","doi-asserted-by":"publisher","first-page":"175","DOI":"10.2967\/jnumed.116.178780","volume":"58","author":"JW D'Souza","year":"2017","unstructured":"D\u2019Souza, J. W. et al. Cerenkov luminescence imaging as a modality to evaluate antibody-based PET radiotracers. J. Nucl. Med. 58(1), 175\u2013180 (2017).","journal-title":"J. Nucl. Med."},{"issue":"1","key":"50779_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2967\/jnumed.107.045799","volume":"49","author":"GD Luker","year":"2008","unstructured":"Luker, G. D. & Luker, K. E. Optical imaging: Current applications and future directions. J. Nucl. Med. 49(1), 1\u20134 (2008).","journal-title":"J. Nucl. Med."},{"issue":"1","key":"50779_CR41","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jphotobiol.2009.11.007","volume":"98","author":"F Leblond","year":"2010","unstructured":"Leblond, F., Davis, S. C., Vald\u00e9s, P. A. & Pogue, B. W. Pre-clinical whole-body fluorescence imaging: Review of instruments, methods and applications. J. Photochem. Photobiol. B 98(1), 77\u201394 (2010).","journal-title":"J. Photochem. Photobiol. B"},{"issue":"2","key":"50779_CR42","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1002\/wnan.7","volume":"1","author":"PP Ghoroghchian","year":"2009","unstructured":"Ghoroghchian, P. P., Therien, M. J. & Hammer, D. A. In vivo fluorescence imaging: A personal perspective. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 1(2), 156\u2013167 (2009).","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"issue":"2","key":"50779_CR43","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3727\/215517914X685169","volume":"7","author":"H Yukawa","year":"2015","unstructured":"Yukawa, H., Watanabe, M., Kaji, N. & Baba, Y. Influence of autofluorescence derived from living body on in vivo fluorescence imaging using quantum dots. Cell Med. 7(2), 75\u201382 (2015).","journal-title":"Cell Med."},{"issue":"10","key":"50779_CR44","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1002\/cmdc.201900181","volume":"14","author":"D Sirbu","year":"2019","unstructured":"Sirbu, D., Luli, S., Leslie, J., Oakley, F. & Benniston, A. C. Enhanced in vivo optical imaging of the inflammatory response to acute liver injury in C57BL\/6 mice using a highly bright near-infrared BODIPY dye. ChemMedChem 14(10), 995\u2013999 (2019).","journal-title":"ChemMedChem"},{"issue":"5","key":"50779_CR45","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1172\/JCI66369","volume":"123","author":"C Yin","year":"2013","unstructured":"Yin, C., Evason, K. J., Asahina, K. & Stainier, D. Y. R. Hepatic stellate cells in liver development, regeneration, and cancer. J. Clin. Investig. 123(5), 1902\u20131910 (2013).","journal-title":"J. Clin. Investig."},{"issue":"3","key":"50779_CR46","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s40139-013-0019-6","volume":"1","author":"JX Jiang","year":"2013","unstructured":"Jiang, J. X. & T\u00f6r\u00f6k, N. J. Liver injury and the activation of the hepatic myofibroblasts. Curr. Pathobiol. Rep. 1(3), 215\u2013223 (2013).","journal-title":"Curr. Pathobiol. Rep."},{"key":"50779_CR47","doi-asserted-by":"publisher","first-page":"671640","DOI":"10.3389\/fphar.2021.671640","volume":"12","author":"P Acharya","year":"2021","unstructured":"Acharya, P., Chouhan, K., Weiskirchen, S. & Weiskirchen, R. Cellular mechanisms of liver fibrosis. Front. Pharmacol. 12, 671640 (2021).","journal-title":"Front. Pharmacol."},{"issue":"9","key":"50779_CR48","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1016\/j.clinthera.2021.07.012","volume":"43","author":"T Hydes","year":"2021","unstructured":"Hydes, T., Brown, E., Hamid, A., Bateman, A. C. & Cuthbertson, D. J. Current and emerging biomarkers and imaging modalities for nonalcoholic fatty liver disease: Clinical and research applications. Clin. Ther. 43(9), 1505\u20131522 (2021).","journal-title":"Clin. Ther."},{"issue":"8","key":"50779_CR49","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1021\/acs.bioconjchem.2c00306","volume":"33","author":"TA Pringle","year":"2022","unstructured":"Pringle, T. A. et al. Synthesis and in vivo evaluation of a site-specifically labeled radioimmunoconjugate for dual-modal (PET\/NIRF) imaging of MT1-MMP in sarcomas. Bioconjug. Chem. 33(8), 1564\u20131573 (2022).","journal-title":"Bioconjug. Chem."},{"issue":"5","key":"50779_CR50","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/s41551-022-00876-4","volume":"6","author":"EC Pratt","year":"2022","unstructured":"Pratt, E. C. et al. Prospective testing of clinical Cerenkov luminescence imaging against standard-of-care nuclear imaging for tumour location. Nat. Biomed. Eng. 6(5), 559\u2013568 (2022).","journal-title":"Nat. Biomed. Eng."},{"key":"50779_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.tipsro.2022.08.011","volume":"24","author":"E Chen","year":"2022","unstructured":"Chen, E. et al. Clinical implementation of the first Cherenkov imaging system in a community-based hospital. Tech. Innov. Patient Support Radiat. Oncol. 24, 1\u20135 (2022).","journal-title":"Tech. Innov. Patient Support Radiat. Oncol."},{"issue":"43","key":"50779_CR52","doi-asserted-by":"publisher","first-page":"27716","DOI":"10.1039\/D2RA05274A","volume":"12","author":"TA Pringle","year":"2022","unstructured":"Pringle, T. A., Coleman, O., Kawamura, A. & Knight, J. C. The influence of degree of labelling upon cellular internalisation of antibody-cell penetrating peptide conjugates. RSC Adv. 12(43), 27716\u201327722 (2022).","journal-title":"RSC Adv."},{"issue":"1","key":"50779_CR53","first-page":"58","volume":"44","author":"JD Sain","year":"2003","unstructured":"Sain, J. D. & Barrett, H. H. Performance evaluation of a modular gamma camera using a detectability index. J. Nucl. Med. 44(1), 58\u201366 (2003).","journal-title":"J. Nucl. Med."},{"issue":"1","key":"50779_CR54","doi-asserted-by":"publisher","first-page":"18431","DOI":"10.1038\/s41598-019-54934-0","volume":"9","author":"V Ilisie","year":"2019","unstructured":"Ilisie, V. et al. High resolution and sensitivity gamma camera with active septa. A first Monte Carlo study. Sci. Rep. 9(1), 18431 (2019).","journal-title":"Sci. Rep."},{"issue":"6","key":"50779_CR55","doi-asserted-by":"publisher","first-page":"5994","DOI":"10.3390\/ijms24065994","volume":"24","author":"BK Jin","year":"2023","unstructured":"Jin, B. K., Odongo, S., Radwanska, M. & Magez, S. Nanobodies: A review of generation, diagnostics and therapeutics. Int. J. Mol. Sci. 24(6), 5994 (2023).","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"50779_CR56","doi-asserted-by":"publisher","first-page":"45","DOI":"10.21164\/pomjlifesci.609","volume":"65","author":"H Piwowarska-Bilska","year":"2019","unstructured":"Piwowarska-Bilska, H., Supi\u0144ska, A., Iwanowski, J., Tyczy\u0144ska, A. & Birkenfeld, B. PET\u2014Advanced nuclear imaging technology for medicine. Pomeranian J. Life Sci. 65(3), 45\u201353 (2019).","journal-title":"Pomeranian J. Life Sci."},{"issue":"4","key":"50779_CR57","doi-asserted-by":"publisher","first-page":"660","DOI":"10.2967\/jnumed.109.072645","volume":"51","author":"J Clanton","year":"2010","unstructured":"Clanton, J. & Sandler, M. P. Molecular imaging: Radiopharmaceuticals for PET and SPECT. J. Nucl. Med. 51(4), 660 (2010).","journal-title":"J. Nucl. Med."},{"key":"50779_CR58","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1146\/annurev-bioeng-071114-040723","volume":"17","author":"JJ Vaquero","year":"2015","unstructured":"Vaquero, J. J. & Kinahan, P. Positron emission tomography: Current challenges and opportunities for technological advances in clinical and preclinical imaging systems. Annu. Rev. Biomed. Eng. 17, 385\u2013414 (2015).","journal-title":"Annu. Rev. Biomed. Eng."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-50779-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-50779-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-50779-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T15:05:34Z","timestamp":1704467134000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-50779-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,5]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["50779"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-50779-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,5]]},"assertion":[{"value":"16 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Wright MC has a financial interest in any commercial exploitation of the C1\u20133 antibody through any licensing agreement of a previous employer but takes no part and has no influence on any commercialisation activities. All other authors declared that they do not have anything to disclose regarding funding or conflict of interest with respect to this manuscript.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"633"}}